Pharmacomechanical thrombolysis combines mechanical clot disruption with localized delivery of a thrombolytic agent in a single catheter-based procedure. This guide explains the general principles behind the approach and how INVAMED's Mantis platform is designed to support it.
What Is Pharmacomechanical Thrombolysis?
Pharmacomechanical thrombolysis, sometimes abbreviated PMT, refers to techniques that pair mechanical thrombus fragmentation or maceration with targeted infusion of a thrombolytic drug. The rationale is that mechanically disrupting the clot exposes additional surface area, which is intended to allow the thrombolytic agent to act more efficiently on the remaining thrombus, potentially supporting a reduced overall drug dose and shorter infusion time compared to catheter-directed thrombolysis (CDT) alone.
How Does the Mantis Platform Support This Approach?
The Mantis rotational thrombectomy system is engineered with pharmacomechanical capability, meaning its rotating leaf-tip mechanism and aspiration lumen are designed to work in conjunction with localized pharmacologic therapy. In practice, this can allow an operator to:
- Mechanically fragment thrombus to increase drug contact surface area
- Aspirate a portion of the fragmented clot burden directly during the procedure
- Deliver thrombolytic agent locally to the remaining thrombus, where clinically indicated
This combined approach is intended to offer flexibility compared to a purely mechanical or purely pharmacologic strategy alone.
What Are the Procedural Considerations?
Pharmacomechanical thrombolysis is typically performed by interventional radiologists, vascular surgeons, or interventional cardiologists in a controlled endovascular setting with fluoroscopic guidance. As with any technique involving thrombolytic agents, bleeding risk must be assessed on a patient-by-patient basis, and contraindications to thrombolytic therapy (such as recent surgery, active bleeding, or certain neurological conditions) should be reviewed before the procedure. All procedures carry risks, and the decision to proceed rests with the treating physician following an individualized assessment.
How Does Pharmacomechanical Thrombolysis Compare to Standalone Approaches?
Compared to catheter-directed thrombolysis alone, pharmacomechanical techniques are designed to potentially shorten treatment time by combining mechanical clearance with drug therapy in a single session, rather than relying solely on a prolonged thrombolytic infusion. Compared to purely mechanical thrombectomy, the addition of localized pharmacologic therapy may help address residual thrombus that mechanical disruption alone does not fully clear. The most appropriate approach depends on clot characteristics, chronicity, and patient-specific factors.
Frequently Asked Questions
Does pharmacomechanical thrombolysis eliminate the need for anticoagulation afterward?
No. Pharmacomechanical thrombolysis addresses existing clot burden, but patients typically continue anticoagulant therapy afterward as determined by their physician to reduce the risk of recurrence.
Is pharmacomechanical thrombolysis suitable for all DVT patients?
No single approach is universally appropriate. Physicians evaluate clot extent, chronicity, bleeding risk, and overall health before selecting pharmacomechanical thrombolysis, mechanical thrombectomy, or CDT alone.
What imaging is used during pharmacomechanical procedures?
Procedures are generally performed under fluoroscopic guidance, often supplemented by venography to confirm catheter position and assess clot clearance during and after the intervention.
Related INVAMED Resources
- Deep Vein Thrombosis (DVT) Product Portfolio
- Comprehensive Catheter & Guidewire Systems
- Request Information from INVAMED
Medical Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. It is not a substitute for consultation with a qualified healthcare professional. Product indications, availability, and regulatory status vary by country. Always refer to the official Instructions for Use (IFU) and consult a licensed physician for guidance specific to your situation. INVAMED devices are intended for use by trained healthcare professionals.